(Q44487839)

3 December 2017

title

Secondary prevention with folic acid: effects on clinical outcomes (English)

1 reference

3 December 2017

1 reference

Dirk J van Veldhuisen

series ordinal

5

object named as

Dirk J van Veldhuisen

1 reference

3 December 2017

4

J Wouter Jukema

1 reference

3 December 2017

3

Aeilko H Zwinderman

1 reference

3 December 2017

Anho Liem

1

1 reference

3 December 2017

Giny H Reynierse-Buitenwerf

series ordinal

2

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

Journal of the American College of Cardiology

3 December 2017

published in

1 reference

3 December 2017

volume

41

1 reference

3 December 2017

issue

12

1 reference

3 December 2017

page(s)

2105-2113

1 reference

Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900485-6

7 January 2021

Plasma homocysteine levels and mortality in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900485-6

7 January 2021

Hyperhomocystinemia: a risk factor or a consequence of coronary heart disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900485-6

7 January 2021

Plasma homocysteine levels and late outcome after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900485-6

7 January 2021

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900485-6

7 January 2021

Homocysteine and atherothrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900485-6

7 January 2021

Effects of Oral Folic Acid Supplementation on Endothelial Function in Familial Hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900485-6

7 January 2021

Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900485-6

7 January 2021

Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900485-6

7 January 2021

Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900485-6

7 January 2021

Decreased rate of coronary restenosis after lowering of plasma homocysteine levels

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900485-6

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900485-6

7 January 2021

Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900485-6

7 January 2021

The controversy over homocysteine and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900485-6

7 January 2021

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900485-6

7 January 2021

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900485-6

7 January 2021

Vitamin status and intake as primary determinants of homocysteinemia in an elderly population

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900485-6

7 January 2021

Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900485-6

7 January 2021

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900485-6

7 January 2021

Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900485-6

7 January 2021

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900485-6

7 January 2021

Fibrinogen: an important risk factor for atherothrombotic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900485-6

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900485-6

7 January 2021

10.1016/S0735-1097(03)00485-6

Identifiers

DOI

1 reference

3 December 2017

1 reference